Signing the deal: Martin Krengel, WEPA’s Chief Executive, and Giovanni Gambini, President of Gambini

German-headquartered tissue producer WEPA has invested in a Gambini-supplied 700m/min consumer converting line.  

The complete line will be started up at the company’s plant in Leuna, Germany. 

Runnability tests have been carried out jointly at TissueHub, the spin-off technology and development centre established by Gambini, offering clients a complete 2.8m-wide pilot line. 

WEPA has a turnover of €1.3bn and plants in six different European countries.